Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2026 08:15 ET | Source: CERo Therapeutics Holdings, Inc.

CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial

Company to initiate third planned cohort at higher dose level, including patients with myelodysplastic syndrome and myelofibrosis SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CERo...